Elanco Animal Health (NYSE: ELAN) reported Q1 EPS of $0.34, $0.08 better than the analyst estimate of $0.26. Revenue for the quarter came in at $1.21 billion versus the consensus estimate of $1.18 billion.

GUIDANCE:

Elanco Animal Health sees FY2024 EPS of $0.88-$0.96, versus the consensus of $0.92. Elanco Animal Health sees FY2024 revenue of $4.46-4.51 billion, versus the consensus of $4.49 billion.

Elanco Animal Health sees Q2 2024 EPS of $0.23-$0.26, versus the consensus of $0.24. Elanco Animal Health sees Q2 2024 revenue of $1.14-1.17 billion, versus the consensus of $1.16 billion.

For earnings history and earnings-related data on Elanco Animal Health (ELAN) click here.